Correction to: Nature Medicine https://doi.org/10.1038/s41591-021-01499-z, published online 3 September 2021.
In the version of this Article initially published, there was an error in the author affiliations. Specifically, affiliation 27, corresponding to author Carlo Selmi, has been corrected from “Humanitas Research Hospital, Milan, Italy” to read: “Department of Biomedical Sciences, Humanitas University, Milan, Italy & IRCCS Humanitas Research Hospital, Milan, Italy.”
The change has been made to the online version of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kyriazopoulou, E., Poulakou, G., Milionis, H. et al. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med 27, 1850 (2021). https://doi.org/10.1038/s41591-021-01569-2
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-021-01569-2
This article is cited by
-
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial
Annals of Intensive Care (2024)
-
Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
European Journal of Medical Research (2023)
-
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Nature Reviews Rheumatology (2022)
-
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022)
Wiener klinische Wochenschrift (2022)
